As of January 2025, Biocon has a market cap of $4.84B. This makes Biocon the world's 2728th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $3.85B | 9.87% |
2023 | $3.51B | -4.66% |
2022 | $3.68B | -28.19% |
2021 | $5.12B | -21.65% |
2020 | $6.54B | 58.46% |
2019 | $4.12B | -6.62% |
2018 | $4.42B | 17.08% |
2017 | $3.77B | 69.70% |
2016 | $2.22B | 83.33% |
2015 | $1.21B | 21.75% |
2014 | $996.05M | -8.04% |
2013 | $1.08B | 61.35% |
2012 | $671.29M | 4.73% |
2011 | $640.98M | -34.93% |
2010 | $985.05M | 52.45% |
2009 | $646.13M | 136.85% |
2008 | $272.80M | -59.62% |
2007 | $675.50M | 54.46% |
2006 | $437.34M | -24.53% |
2005 | $579.48M | -2.72% |
2004 | $595.69M | - |